Diabetes Clinical Trials in San Antonio

Showing 421-440 of 489 trials

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

NCT00476931

The purpose of the study is to study the clinical effects of the investigational drug, SB-509 versus placebo in patients with diabetic neuropathy.

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy

Sangamo Therapeutics91 participantsStarted May 2007

La Jolla, California, United States • Lakewood, California, United States • Lomita, California, United States +17 more locations

COMPLETEDPhase 2< 1 mile

Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509

NCT00665145

The primary and secondary objectives of this study are: Primary: To evaluate stem-cell-mobilization in subjects with diabetic neuropathy receiving SB-509. Stem cell mobilization will be assessed by evaluating the presence of stem cells circulating in peripheral blood. Secondary: To evaluate the safety of SB-509 in subjects treated with SB-509 with diabetic neuropathy; and to compare the effect of SB-509 versus placebo on a pre-defined multi-endpoint analysis that includes visual analog scale for pain intensity (VASPI), total neuropathy score (TNS), evoked nerve conduction velocity (NCV) and quantitative sensory testing (QST)

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy

Sangamo Therapeutics23 participantsStarted Jan 2008

La Jolla, California, United States • Walnut Creek, California, United States • Houston, Texas, United States +1 more locations

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509

Diabetes Trials in Other Cities

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

Follow-Up Study for Exubera

Mechanisms of Glucose Lowering Effect of Colesevelam HCl

A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia

A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease

Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Exploratory Study of Iocide Oral Rinse in a Diabetic Population

A Study to Evaluate the Pharmacodynamic Effects of Single-Dose Co-Administration of LX4211 With Januvia® in Type 2 Diabetics

WelChol® and Insulin in Treating Patients With Type 2 Diabetes

Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Safety Study of BMS-903452 in Healthy Subjects (Panel 1-7) & Relative Bioavailability of the Crystalline and Amorphous Forms of BMS-903452 [Panels 4, 6, 11 & 12(Part A)], and Subjects With Type 2 Diabetes Mellitus (Part B)

Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment

Testing the Developmental Origins Hypothesis

Other Conditions in San Antonio